Recon: Gilead warns of counterfeit HIV medicines in US; Novavax delays seeking approval for its COVID vaccine

Recon

ReconMichael Mezher

Biologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy